Bardin Hill Management Partners LP Has $12 Million Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)

Bardin Hill Management Partners LP grew its position in shares of Amedisys, Inc. (NASDAQ:AMED) by 3.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 124,342 shares of the health services provider’s stock after purchasing an additional 3,871 shares during the quarter. Amedisys accounts for 5.6% of Bardin Hill Management Partners LP’s portfolio, making the stock its 4th largest position. Bardin Hill Management Partners LP owned about 0.38% of Amedisys worth $12,000,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. KBC Group NV acquired a new position in Amedisys during the third quarter worth about $63,000. Innealta Capital LLC bought a new position in shares of Amedisys during the 2nd quarter valued at about $64,000. Signaturefd LLC grew its stake in shares of Amedisys by 88.2% in the 2nd quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock worth $104,000 after purchasing an additional 530 shares during the last quarter. CWM LLC raised its holdings in shares of Amedisys by 14.5% in the 3rd quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after purchasing an additional 277 shares in the last quarter. Finally, Crossmark Global Holdings Inc. bought a new stake in shares of Amedisys in the 3rd quarter worth approximately $243,000. Institutional investors own 94.36% of the company’s stock.

Amedisys Trading Up 0.2 %

Shares of NASDAQ:AMED opened at $91.41 on Monday. The stock has a market capitalization of $2.99 billion, a price-to-earnings ratio of 36.27, a PEG ratio of 1.92 and a beta of 0.78. Amedisys, Inc. has a 1-year low of $88.81 and a 1-year high of $98.95. The company has a 50 day moving average price of $94.74 and a 200 day moving average price of $95.62. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19.

Amedisys (NASDAQ:AMED) last released its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.19). The company had revenue of $587.67 million for the quarter, compared to the consensus estimate of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business’s revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.98 earnings per share. On average, research analysts anticipate that Amedisys, Inc. will post 4.55 EPS for the current fiscal year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.